carglumic acid has been researched along with Liver Dysfunction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, P; Gu, X; Huang, HY; Liang, XF; Wu, XF; Xue, M | 1 |
| Cho, H; Kim, S; Kim, WH; Kwak, YS; Lee, JH; Paik, WK | 1 |
2 other study(ies) available for carglumic acid and Liver Dysfunction
| Article | Year |
|---|---|
Dietary N-Carbamylglutamate (NCG) alleviates liver metabolic disease and hepatocyte apoptosis by suppressing ERK1/2-mTOR-S6K1 signal pathway via promoting endogenous arginine synthesis in Japanese seabass (Lateolabrax japonicus).
Topics: Animal Feed; Animals; Apoptosis; Arginine; Bass; Diet; Dietary Supplements; Dose-Response Relationship, Drug; Fish Diseases; Fish Proteins; Glutamates; Hepatocytes; Liver Diseases; Metabolic Diseases; Nutrients; Random Allocation; Signal Transduction | 2019 |
N-carbamoyl-L-glutamate plus L-arginine can protect ammonia intoxication in rats with reduced functional liver mass.
Topics: Acetates; Ammonia; Animals; Arginine; Behavior, Animal; Blood Urea Nitrogen; Glutamates; Hepatectomy; Liver; Liver Diseases; Male; Organ Size; Rats; Rats, Sprague-Dawley | 1998 |